Population
Patients with diabetic neuropathy
Design
Review
Authors
Loading...
Reinforces glycemic control plus symptomatic drugs for diabetic neuropathy care now; leaves open optimal regimens for prospective trials.
This review highlights the multifaceted nature of diabetic neuropathy and summarizes the array of pharmacological options available for symptomatic management, emphasizing glycemic control as foundational.
Duby et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: